For COVID-19 guidance documents, including health guidances and licensure and regulatory information, please visit coronavirus.dc.gov/healthguidance.
COVID-19 Health Notices
(For non-COVID health notices, scroll down to the next section.)
- Coronavirus Disease(COVID-19): Use of Oral Antiviral Medications for COVID-19 Illness (UPDATED: April 29, 2022)
- Coronavirus Disease(COVID-19): Emergency Use Authorization Revisions to Evusheld Dosing (NEW: March 9, 2022)
- Coronavirus Disease(COVID-19): FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (January 31,2022)
- COVID-19 Vaccine Side Effects (May 28, 2021)
- Update: COVID-19 Messenger RNA Vaccines (May 25, 2021)
- Coronavirus Disease (COVID-19): Multisystem Inflammatory Syndrome in Children (MIS-C) (April 9, 2021)
- Coronavirus Disease (COVID-19): COVID-19 Outbreak Investigation and Reporting Requirements (March 10, 2021)
- Coronavirus Disease (COVID-19): Guidance on Janssen COVID-19 Vaccine (March 9, 2021)
- Coronavirus Disease(COVID-19): SARS-CoV-2 Variants (February 11, 2021)
- Coronavirus Disease(COVID-19): Updated Guidance on SARS-CoV-2 Antigen Testing (February 2, 2021)
- Guidance on COVID-19 Vaccination (UPDATED: March 10, 2021)
- SARS-CoV-2 Antigen Testing - Updated (December 28, 2020)
- Updated Priorities for COVID-19 Testing, Guidelines for Reporting, and Discontinuation of Home Isolation (August 3, 2020)
- Reporting Laboratory-Confirmed COVID-19 in Healthcare Personnel (July 15, 2020)
- Pediatric Multi-System Inflammatory Syndrome Possibly Associated with COVID-19 (May 11, 2020)
- COVID-19 Testing and Guidelines for Clearance (May 7, 2020)
- Coronavirus Disease (COVID-19): Updated Process for Testing Patients with Suspected COVID-19 (April 21, 2020)
- Coronavirus Disease (COVID-19): Updated Priorities for Testing Patients with Suspected COVID-19 and Updated Prioritization of Contact Tracing by DC Health (March 26, 2020)
- Coronavirus Disease (COVID-19): Update on Testing Guidance for Discontinuing Home Isolation (March 20, 2020)
- Update on Testing and PPE Recommendations Coronavirus Disease 2019 (COVID-19) (March 13, 2020)
- Update and Interim Guidance: Coronavirus Disease 2019 (COVID-19) (March 5, 2020)
- Update and Interim Guidance: Coronavirus Disease 2019 (COVID-19) (February 28, 2020)
- Update and Interim Guidance on Novel Coronavirus (2019-nCoV) Outbreak (January 28, 2020)
- January 23, 2020 - Update and Interim Guidance on 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China (Updated 1/28/20)
- January 10, 2020 - Outbreak of Pneumonia of Unknown Etiology (PUE) in Wuhan, China
Health Notices
2022
- May 16, 2022 - Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response
- May 3, 2022 - Call for Cases: Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
- March 3, 2022- CALL For CASES: Cronobacter Sakazakii
2021
- April 7, 2021 - Resurgence of Candida auris in the District of Columbia
- March 5, 2021 - Ebola Virus Disease Situational Update
- May 21, 2021- Ebola Virus Disease Situational Update
2020
- Acute Flaccid Myelitis Recommendations and Reporting (August 7, 2020)
- July 1, 2020 - Rapid Antiretroviral Therapy (ART) Initiation for People Diagnosed with HIV
- January 30, 2020 - Syphilis Testing During Pregnancy
- January 13, 2020 - Reporting and Containment of Emerging Multidrug-Resistant Organisms in Healthcare Settings
2019
- October 3,2019 - 2019-2020 Influenza Season Surveillance and Vaccine Updates
-
- January 10, 2019 - CALL FOR CASES: Antibiotic-Resistant Infections Following Invasive Medical Procedures in Mexico
2018
- December 11, 2018 - Guidance on Mumps Testing and Control Measures
- November 20, 2018 - Multistate Outbreak of Multidrug-Resistant Salmonella Infections Linked to Raw Turkey Products
- November 5, 2018 - Acute Flaccid Myelitis Recommendations and Reporting—2018
- October 11, 2018 - Guidance and Recommendations for Hepatitis A Virus Testing, Prevention and Control Measures
- October 10, 2018 - 2018-2019 Influenza Season Surveillance and Vaccine Updates
- September 27, 2018 - Updated Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika
- August 21, 2018 - Increased Vigilance for Middle East Respiratory Syndrome Among Persons Who Travel to Saudi Arabia for the Annual Pilgrimage (Hajj)
- August 6, 2018 - West Nile virus Updates
- July 19, 2018 - CALL FOR CASES: Acinetobacter Calcoaceticus-Baumannii (ACB) Complex Sepsis Associated with Platelet Transfusion
- July 16, 2018 - Vibrio Parahaemolyticus Disease Cluster Investigation
- July 13, 2018 - Prevention and Management of Legionnaires’ Disease— A Disease of Increasing National Significance
- May 17, 2018 - Online Reporting of HIV, Hepatitis B and C, and Sexually Transmitted Diseases
- May 14, 2018 - Updates to Vector-borne Disease Screening and Reporting Guidelines
- April 18, 2018 - Updated Zika Virus Testing Recommendations and Utilization of DC Public Health Laboratory
- April 6, 2018 - Health Notice for District of Columbia Healthcare Providers: Coagulopathy in Patients Reporting Synthetic Cannabinoid Use
- January 25, 2018 - 2017-2018 Influenza Season Surveillance and Vaccine Updates
2017
- November 17, 2017 - Updates on Zika Virus Disease and Testing
- November 3, 2017 - Guidance on Mumps Testing and Control Measures (UPDATED)
- October 3, 2017 - 2017–2018 Influenza Season Surveillance and Vaccine Updates
- August 25, 2017 - Updates on Zika Virus Disease and Testing
- August 24, 2017 - Increased Vigilance for Middle East Respiratory Syndrome Among Persons Who Travel to Saudi Arabia for the Annual Pilgrimage (Hajj)
- August 24, 2017 - Outbreak of Nontuberculous Mycobacterium Infections Following Cosmetic Surgery Performed in the Dominican Republic
- July 5, 2017 - Updated Reporting Requirements for Notifiable Diseases and Conditions
- June 30, 2017 - Updates on Zika Virus Disease and Testing
- May 23, 2017 - Confirmed Measles Case in the District of Columbia (UPDATED)
- May 22, 2017 - Confirmed Measles Case in the District of Columbia
- May 1, 2017 - Recommendations for Diagnosing and Managing Shigella Strains with Possible Reduced Susceptibility to Ciprofloxacin
- March 15, 2017 - Updates on Zika Virus Disease and Testing
- January 24, 2017 - Updates on Zika Virus Disease and Testing
2016
- October 18, 2016 - New Procedures and Updates on Zika Testing
- September 19, 2016 - Updates and Reminders on Zika Virus Disease
- August 3, 2016 - Updates and Reminders on Zika Virus Disease
- June 13, 2016 - Update and Reminders on Zika Virus Disease: Testing, Guidance, and Health Messages
- May 13, 2016 - Update on Zika Virus Disease: Surveillance, Guidance, and Health Messages
- March 31, 2016 - Update on Zika Virus Disease Recommendations and Guidance
- February 10, 2016 - Update on Zika Virus Disease Testing
- February 1, 2016 - Update on Zika Virus Disease Testing
- January 21, 2016 - Update on Travel-Associated Illnesses: Zika and Ebola Virus Disease